All posts

iA Capital launches on Sabio with a Buy rating

iA Capital Markets initiated coverage on Thursday on  Sabio Holdings (Sabio Holdings Stock Quote, Charts, News, Analysts, Financials TSXV:SBIO), starting the stock off with a “Buy” rating and 12-month target price of C$2.90 per share, which at press time was good for a projected return of 195.9 per cent. iA analyst Neehal Upadhyaya said SBIO is trading well below its peer group despite a better growth profile and positive EBITDA.

Sabio is a tech provider for the advertising-supported Video on Demand (VOD) and streaming industry with three subsidiaries. The company’s App Science platform provides privacy compliant, non-cookie, cross-screen household data from 55 million validated homes and 110 million connected TV (CTV) devices for insights on consumer behaviour. 

Its Vidillion business, acquired in April, 2022, creates, distributes and manages ad-supported CTV and OTT (over-the-top) apps on streaming platforms like Roku, Vizio and Disney+. Finally, its Sabio business works with major brands and agencies through its proprietary DSP and ad server to deliver targeted ad campaign solutions.

Upadhyaya said the still growing trend to cord-cutting of traditional TV-watching in favour of VOD has shifted the advertising landscape.

“With the shifting audience and the inherent lack of data driven targeting, brands are following eye-balls and shifting their advertising budgets to VOD platforms as they allow for greater return on advertising spend (RoAS) through analytically guided marketing campaigns,” Upadhyaya wrote.

The analyst sees Sabio’s suite of ad tech solutions demonstrating its value to customers, allowing them to dynamically modify their ad campaigns through App Science, which Upadhyaya called a key differentiator. Moreover, he said Sabio should be able to capture a larger portion of its customers’ marketing budgets as that value is realized.

“Sabio has been able to attract a strong group of blue-chip customers, enabling it to grow by ~80 per cent over the past two years despite the continued softness in the macroeconomic environment. By leveraging the insights provided by App Science, SBIO can solidify its positioning within the many demand-side platforms that are used by its customers,” he said.

By the numbers, Upadhyaya is forecasting Sabio’s revenue to go from $42 million in 2022 to $55 million in 2023 and to $68 million in 2024. He is forecasting adjusted EBITDA to go from $1.3 million in 2022 to $0.8 million in 2023 and to $4.8 million in 2024.

Upadhyaya’s C$2.90 target is based on a 1.5x multiple of his 2024 EV/Revenue estimate, which he said is well below SBIO’s peer group average at 3.3x.

“Despite a superior growth profile compared to its AdTech peers, achieving positive Adj. EBITDA, and supporting its growth strategy from FCF, the Company is trading at just 0.5× our 2024E revenue estimate,” Upadhyaya wrote.

“We believe the current risk-to-reward ratio is compelling and Sabio represents an excellent opportunity for investors who want to invest in an AdTech story at a de-risked valuation level,” he said.

Disclosure: Sabio Holdings is an annual sponsor of Cantech Letter.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

13 hours ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

14 hours ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

14 hours ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

3 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

3 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

4 days ago